One of the intended effects of GLP-1 medications is to slow digestion, which means food sits in the stomach and small intestine longer than usual, giving gut bacteria more time to ferment sulfur-containing foods and producing hydrogen sulfide as a byproduct
While both companies that have a monopoly on these drugs (Novo Nordisk and Eli Lilly) have enjoyed an incredible run-up from 2020 to 2024, both are now in a drawdown
GLP-1 therapy addresses central appetite signaling and metabolic regulation and is extremely effective at treating underlying endocrine and inflammation
Suppliers may request identification documents to verify your age and identity before processing orders
Compassionate care is at the heart of what we do
Graham Lipkin, Consultant Nephrologist at Queen Elizabeth Hospital Birmingham, "Those who take tacrolimus/ciclosporin should have their levels checked." This additional monitoring is crucial when initiating GLP-1 therapy due to the potential for drug interactions